Inogen appoints Andy Reding as new president and chief executive officer
Inogen, Inc. announced that its board has named Andy Reding as president and chief executive officer, effective immediately. Reding, who joined the company as chief operating officer in July 2026, replaces outgoing CEO Kevin Smith and will also take a seat on the board of directors. The board chair, Elizabeth Mora, said the transition is timely as the company pursues growth and recent strategic actions.
Why it matters
The leadership change could shape Inogen’s execution of its growth strategy and the integration of recent divestitures. Investors will watch how the new CEO’s experience in scaling med‑tech businesses translates into future performance.
Key facts
- 1Andy Reding was appointed president and chief executive officer of Inogen, effective immediately. stocktitan.net
- 2Reding replaces Kevin Smith as CEO. investing.com
- 3Reding had been serving as chief operating officer since July 2026. stocktitan.net
- 4Reding will also join Inogen’s board of directors. investing.com
- 5Board chair Elizabeth Mora said the board determined the timing was right for the leadership transition. stocktitan.net
- 6Inogen will separately announce its third‑quarter 2026 financial results, for the quarter ended September 30, 2026. stocktitan.net
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.